Drugs / beacizumab
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT04131803 Background | Oct 2021 → Nov 2022 | colorectal cancer | Second Affiliated Hospital, School of Medicine, Zhejiang University | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | beacizumab | “beacizumab 7.5 mg/kg intravenous day 1” NCT04131803 ↗ |
| Route | Intravenous | “beacizumab 7.5 mg/kg intravenous day 1” NCT04131803 ↗ |